Evidence map›Paper›PMID 41929037›Full record

ArticlebioRxiv : the preprint server for biology2026

MaRNAV-1, an intracellular virus of

Dynang Seng, Katie Ko, Agnes Orban, Sokleap Heng, Lionel Brice Feufack-Donfack, Janne Grünebast, Nisa Ya, Franck Dumetz, Kieran Tebben, Tiziano Vignolini and 22 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Dynang SengMalaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Katie KoInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, USA.
Agnes OrbanMalaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Sokleap HengMalaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Lionel Brice Feufack-DonfackMalaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Janne GrünebastInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, USA.
Nisa YaImmunology Unit, Institut Pasteur du Cambodge, Institut Pasteur International Network, Phnom Penh 120210, Cambodia.
Franck DumetzInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, USA.
Kieran TebbenInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, USA.
Tiziano VignoliniInstitut Pasteur, Université Paris Cité, INSERM U1347, G5 Parasite RNA Biology Group, F-75015 Paris, France.
Gregory DoreInstitut Pasteur, Université Paris Cité, INSERM U1347, G5 Parasite RNA Biology Group, F-75015 Paris, France.
Nimol KhimMalaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Jeremy SalvadorMalaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Zainab OuaidMalaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Thierry LefèvreMIVEGEC, IRD, CNRS, University of Montpellier, 34090 Montpellier cedex 5, France.
Anna CohuetMIVEGEC, IRD, CNRS, University of Montpellier, 34090 Montpellier cedex 5, France.
Cecile SommenEpidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Claude FlamandEpidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Anthony A RubertoDepartment of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, Florida, USA.
Abnet AbebeEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Meshesha TsigieEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Geremew TasewEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Getachew TolleraEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Benoit MalleretDepartment of Microbiology and Immunology, Immunology Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Tassew Tefera ShenkutieDepartment of Microbiology and Immunology, College of Medicine, Drexel University, Philadelphia, USA.
Eugenia LoDepartment of Microbiology and Immunology, College of Medicine, Drexel University, Philadelphia, USA.
Nicholas M AnsteyGlobal and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.
Mary E PetroneSydney Infectious Diseases Institute, School of Medical Sciences, The University of Sydney, Sydney, NSW 2006, Australia.
Tineke CantaertImmunology Unit, Institut Pasteur du Cambodge, Institut Pasteur International Network, Phnom Penh 120210, Cambodia.
Sebastian BaumgartenInstitut Pasteur, Université Paris Cité, INSERM U1347, G5 Parasite RNA Biology Group, F-75015 Paris, France.
David SerreInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, USA.
Jean PopoviciMalaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.ORCID 0000-0002-3135-1175

Funding

Understanding, tracking and eliminating malaria transmission in the Asia - Pacific RegionU19AI129392 · NIAID · WALTER AND ELIZA HALL INST MEDICAL RES · PI Ivo J Mueller, Leanne Robinson · 2017 to 2026
$7.1M
Rigorous Assessment of P. vivax Relapses and Primaquine Efficacy for Radical CureR01AI146590 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SERRE, DAVID · 2020 to 2024
$3.0M
Extent, dynamics and mechanisms of Plasmodium vivax immune evasion caused by PvDBP gene amplificationR01AI173171 · NIAID · INSTITUT PASTEUR DU CAMBODGE · PI Eugenia Lo, Jean POPOVICI · 2023 to 2026
$2.4M
Comprehensive characterization of the genetic factors and the host immune response associated to protection from clinical Plasmodium vivax malariaR01AI175134 · NIAID · INSTITUT PASTEUR DU CAMBODGE · PI TINEKE CANTAERT, Jean POPOVICI · 2023 to 2026
$2.3M
Leveraging access to parasite natural diversity to identify Plasmodium vivax culture-adaptable strain.R61AI187100 · NIAID · INSTITUT PASTEUR DU CAMBODGE · PI Jean POPOVICI · 2025 to 2026
$533k
NIAID NIH HHS R01 AI146590NIAID NIH HHS R01 AI173171NIAID NIH HHS R01 AI175134NIAID NIH HHS R61 AI187100NIAID NIH HHS U19 AI129392
6 · The paper itself

Abstract

MaRNAV-1 is an RNA virus recently identified in

Indexed as

host immune responseMaRNAV-1Plasmodium transmissionPlasmodium vivaxvirus-parasite interactions

Identifiers

PMID41929037
PMCPMC13042012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.